HeyJaredHard Truths By Vertex
Vertex Ventures Southeast Asia & India is a pioneer in investing in tech start-ups in this region and has helped to build a number of unicorns.
- Indexed episodes, last 90 days
- 3
- Latest publication
- Sep 9, 2026
- Audience
- Checking…
- Earliest in this view
- Aug 6, 2026
Latest episodes
Why Al Never Got Cheaper | Lemuel Low, Ren3 (opens the original)
Read excerpt
I sat down with an AI founder who believes companies are spending first… and asking what it cost later. Lemuel Low is building Ren3 to help businesses understand, control and optimise the rapidly growing cost of AI. As enterprises deploy copilots, autonomous agents and increasingly complex workflows, many are discovering that traditional software budgets simply do not work when every outcome carries a different and potentially uncapped token cost.We spoke about why AI never became as cheap as pr
Why India's Rich Are Choosing Villas Over Hotels | Ritwik Khare & Karan Miglani, Elivaas (opens the original)
Read excerpt
They went from three villas to 600 in just over two years — by betting that India’s next major travel brand would look less like a hotel and more like someone’s dream home. Ritwik Khare and Karan Miglani, co-founders of ELIVAAS, had worked together in travel before building a company at the intersection of hospitality and real estate. They saw a growing market of second-home owners who needed help maintaining, monitoring and monetising their properties — and travellers who wanted the privacy of
The ₹500 Cr Startup Making Ayurveda Work Like Modern Medicine | Ameve Sharma, Kapiva (opens the original)
Read excerpt
He wants to build the “herbal Pfizer”... and he’s betting Kapiva’s future on proof, not blind faith. I sat down with Ameve Sharma, founder of Kapiva, to understand how his personal connection to Ayurveda became a mission to bring 5,000 years of Indian medicine into modern healthcare. We unpacked his journey of scaling Kapiva, investing heavily in clinical trials, challenging traditional thinking, and convincing manufacturers to meet standards nobody else was asking for. Ameve explains why Ayurve
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.